Observational, Non-Interventional Study Supporting Validation of eVO2peak Using Results in Patients Receiving Standard of Care Cardiopulmonary Exercise Tests (CPET)

Part of paid clinical trials in Scottsdale, Arizona.

Sponsor
Prolaio
Study ID
NCT05678530
Status
Recruiting

Conditions

  • Cardiopulmonary

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Accepted

Study Details

In this study, the hypothesis being explored is that peak VO2 and potentially other CPET parameters can be accurately estimated from biosignals (namely, motion from accelerometers and cardiopulmonary variables from EKG) collected during activities of daily living using FDA-cleared wearable biosensors worn by study participants. This study will aim to collect data using wearable biosensors from standard of care patients toward the development of an algorithm that can estimate peak VO2 (eVO2peak) from biosensor data. In addition, this study will explore to further develop other estimated measurements typically reported in CPET, such as VE/VCO2 slope, as well as selected and measures of Left Ventricular Function (diastolic and systolic) typically reported in echocardiogram; instead using wearable biosensors from standard of care testing. A total of 2000 participants will be enrolled including: (Normal) 100 participants, self-reported healthy male and female participants aged 18 to 80 and (Standard of Care) 1900 participants.

Key Dates

First listed
Jan 10, 2023
Start date
Jun 6, 2019
Status verified
Sep 2026
Primary completion
Dec 31, 2027
Completion
Dec 31, 2027

Study Design

Enrollment
2,000 participants (estimated)

Arms

  • Arm: Healthy
    Healthy Subjects who undergo the CPET, or an ECHO, or both CPET and ECHO, as part of routine Standard of Care
  • Arm: Standard of Care
    Standard of Care subjects who undergo the CPET, or an ECHO, or both CPET and ECHO, as part of routine Standard of Care

Primary Outcome Measure

Collect development and validation data for a peak VO2 (eVO2peak) machine learning algorithm and to evaluate the performance of the algorithm. [ Time Frame: From enrollment to the end of collection at 7 days ]

Central Contacts

Locations (15)

FacilityCityStateZIPSite coordinators
Mayo Clinic ArizonaScottsdaleArizona85259
Research Technologist
480-301-6021
Courtney Wheatley-Guy, PhD (PRINCIPAL_INVESTIGATOR)
VA Palo Alto Healthcare SystemPalo AltoCalifornia94304
Clinical Research Coordinator
650-493-5000
Jonathan Myers, PhD (PRINCIPAL_INVESTIGATOR)
University of California San FranciscoSan FranciscoCalifornia94143
Clinical Research Coordinator
415-476-2060
Theodore Abraham, MD (PRINCIPAL_INVESTIGATOR)
The Lundquist InstituteTorranceCalifornia90502
Program Manager
310-222-2425
Study Coordinator
William Stringer, MD (PRINCIPAL_INVESTIGATOR)
Nemours Cardiac CenterWilmingtonDelaware19803
Research Program Manager
302-521-8311
Takeshi Tsuda, MD (PRINCIPAL_INVESTIGATOR)
Memorial Healthcare System, Office of Human ResearchHollywoodFlorida33021
Clinical Research Coordinator
954-265-1849
Iani Patsias, MD (PRINCIPAL_INVESTIGATOR)
Mayo Clinic FloridaJacksonvilleFlorida32224
Clinical Research Coordinator
(513) 313-7710
Bryan J. Taylor, PhD (PRINCIPAL_INVESTIGATOR)
New Generation of Medical ResearchNaplesFlorida34116-
physIQChicagoIllinois60606-
University of Illinois Hospital & Health Sciences SystemChicagoIllinois60608-
Advocate Aurora Health InstituteOakbrook TerraceIllinois60181-
Mayo ClinicRochesterMinnesota55905
Associate Clinical Research Coordinator
507-422-0541
Thomas P. Olson, PhD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White Research InstituteDallasTexas75246
Research Enrollment Analyst
(214) 818-7621
Mark Millard, MD (PRINCIPAL_INVESTIGATOR)
Baylor Scott & White The Heart Hospital - PlanoPlanoTexas75093
Supervisor Clinical Research
469-814-3524
Aasim M. Afzal, MD (PRINCIPAL_INVESTIGATOR)
Intermountain Medical CenterMurrayUtah84107
Project Coordinator, Outpatient Pulmonary Research
801-507-4800
Matthew J. Hegewald, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Scottsdale, AZ

Related Studies